TrialDiabetes care2024

Outcomes With Finerenone in Patients With Chronic Kidney Disease and Type 2 Diabetes by Baseline Insulin Resistance.

Thomas Ebert et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.